Comparison of long-term immunogenicity (23 y) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children

References

• Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958 - 64; http://dx.doi.org/10.1016/j.vaccine.2007.06.059; PMID: 17714836
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al, Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336:1855 - 9; http://dx.doi.org/10.1056/NEJM199706263362602; PMID: 9197213
   PubMed Web of Science ®Google Scholar
• Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003; 69:471 - 4; http://dx.doi.org/10.1002/jmv.10333; PMID: 12601753
   PubMed Web of Science ®Google Scholar
• Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008; 197:1419 - 26; http://dx.doi.org/10.1086/587695; PMID: 18444799
   PubMed Web of Science ®Google Scholar
• van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006; 193:1528 - 35; http://dx.doi.org/10.1086/503433; PMID: 16652281
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26:6266 - 73; http://dx.doi.org/10.1016/j.vaccine.2008.09.056; PMID: 18848855
   PubMed Web of Science ®Google Scholar
• Elavia AJ, Marfatia SP, Banker DD. Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine. Vaccine 1994; 12:87 - 90; http://dx.doi.org/10.1016/0264-410X(94)90015-9; PMID: 8303946
   PubMed Web of Science ®Google Scholar
• Egemen A, Aksit S, Kurugöl Z, Erensoy S, Bilgiç A, Akilli M. Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children. Vaccine 1998; 16:1511 - 5; http://dx.doi.org/10.1016/S0264-410X(98)80006-6; PMID: 9711797
   PubMed Web of Science ®Google Scholar
• Duval B, Boulianne N, De Serres G, Laflamme N, De Wals P, Massé R, et al. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children. Vaccine 2000; 18:1467 - 72; http://dx.doi.org/10.1016/S0264-410X(99)00422-3; PMID: 10618544
   PubMed Web of Science ®Google Scholar
• Goh KT, Tan KL, Kong KH, Oon CJ, Chan SH. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Bull World Health Organ 1992; 70:233 - 9; PMID: 1600584
   PubMed Web of Science ®Google Scholar
• Chiaramonte M, Majori S, Ngatchu T, Moschen ME, Baldo V, Renzulli G, et al. Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity. Vaccine 1996; 14:135 - 7; http://dx.doi.org/10.1016/0264-410X(95)00148-T; PMID: 8852410
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine 2010; 28:623 - 31; http://dx.doi.org/10.1016/j.vaccine.2009.10.068; PMID: 19887132
   PubMed Web of Science ®Google Scholar
• ul-Haq N, Hasnain SS, Umar M, Abbas Z, Valenzuela-Silva C, Lopez-Saura P. Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine 2003; 21:3179 - 85; http://dx.doi.org/10.1016/S0264-410X(03)00232-9; PMID: 12804846
   PubMed Web of Science ®Google Scholar
• Schiff GM, Sherwood JR, Zeldis JB, Krause DS. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J Adolesc Health 1995; 16:12 - 7; http://dx.doi.org/10.1016/1054-139X(94)00105-N; PMID: 7742331
   PubMed Web of Science ®Google Scholar
• Xu HW, Zhuang GH, Wang XL, Chen QJ, Chen ZJ. Efficacy and immune memory of plasmaderived hepatitis B vaccine 11 years after primary immunization. Chin J Prev Med 2000; 34:113 - 5
   Google Scholar
• Möst J, Larcher C, Vogetseder W, Prodinger WM, Huemer HP, Ebenbichler CF, et al. Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students. Vaccine 1992; 10:740 - 1; http://dx.doi.org/10.1016/0264-410X(92)90507-G; PMID: 1308114
   PubMed Web of Science ®Google Scholar
• Chiaramonte M, Majori S, Ngatchu T, Moschen ME, Baldo V, Renzulli G, et al. Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity. Vaccine 1996; 14:135 - 7; http://dx.doi.org/10.1016/0264-410X(95)00148-T; PMID: 8852410
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009; 200:1390 - 6; http://dx.doi.org/10.1086/606119; PMID: 19785526
   PubMed Web of Science ®Google Scholar
• But DY, Lai CL, Lim WL, Fung J, Wong DKH, Yuen MF. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine 2008; 26:6587 - 91; http://dx.doi.org/10.1016/j.vaccine.2008.09.034; PMID: 18835318
   PubMed Web of Science ®Google Scholar
• Lai CL, Yuen MF. The natural history of chronic hepatitis B. J Viral Hepat 2007; 14:Suppl 1 6 - 10; PMID: 17958636
   PubMed Web of Science ®Google Scholar
• Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733 - 45; http://dx.doi.org/10.1056/NEJM199712113372406; PMID: 9392700
   PubMed Web of Science ®Google Scholar
• Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 2003; 187:134 - 8; http://dx.doi.org/10.1086/345871; PMID: 12508157
   PubMed Web of Science ®Google Scholar
• Xu HW, Li DS, Xu JW, Zhuang GH, Wang XL. [Evaluation of long-term efficacy on plasma-derived hepatitis B vaccine]. Zhonghua Liu Xing Bing Xue Za Zhi 1992; 13:362 - 5; PMID: 1303319
   PubMedGoogle Scholar
• Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 2011; 29:2302 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.01.025; PMID: 21277403
   PubMed Web of Science ®Google Scholar